Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Trevisani

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Urologic Oncology|November 11, 2022
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center studyGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologia Internationalis|November 18, 2025
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy EligibilityPietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, et al.
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Characterisation of the immune-related transcriptome in resected biliary tract cancersMichele Ghidini, Luciano Cascione, Pietro Carotenuto, et al.
Urologic Oncology|January 29, 2025
Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scoresMattia Longoni, Giuseppe Rosiello, Pietro Scilipoti, et al.
Translational Andrology and Urology|March 14, 2022
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological studyFrancesco Cianflone, Dejan Lazarevic, Anna Palmisano, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Kidney International Reports|February 24, 2025
Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [<i>Kidney International Reports</i> Volume 9, Issue 5, May 2024, Pages 1419-1428]Rosa Rodríguez-Rodríguez, Mads Hornum, Ana Elena Rodríguez Rodríguez, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Urologic Oncology|November 11, 2022
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center studyGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologia Internationalis|November 18, 2025
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy EligibilityPietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, et al.
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Characterisation of the immune-related transcriptome in resected biliary tract cancersMichele Ghidini, Luciano Cascione, Pietro Carotenuto, et al.
Urologic Oncology|January 29, 2025
Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scoresMattia Longoni, Giuseppe Rosiello, Pietro Scilipoti, et al.
Translational Andrology and Urology|March 14, 2022
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological studyFrancesco Cianflone, Dejan Lazarevic, Anna Palmisano, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Kidney International Reports|February 24, 2025
Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [<i>Kidney International Reports</i> Volume 9, Issue 5, May 2024, Pages 1419-1428]Rosa Rodríguez-Rodríguez, Mads Hornum, Ana Elena Rodríguez Rodríguez, et al.
Pageof 8